A systematic review found that bilateral salpingectomy is associated with roughly an 80% reduction in risk for the serous ...

In the field of cancer medicine, the prevailing wisdom is that early detection and diagnosis saves lives. Catching cancer at earlier stages generally improves patient outcomes and increases chances of ...

Women with certain genetic mutations are at extremely high risk of ovarian cancer. Now, some researchers are trying a new ...

Eli Lilly and Co. has received the Federal Drug Administration’s breakthrough therapy designation for a drug in development ...

Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer ...

Scientific advances and more accessible genetic testing have made removal of the ovaries and fallopian tubes the recommended way to treat certain people at high risk of ovarian cancer. The results of ...

The province is expanding access to a life-saving made-in-B.C. procedure that dramatically reduces the risk of occurrence of ...

Some scientists have suspected that the most common form of ovarian cancer may originate in the fallopian tubes, the thin fibrous tunnels that connect the ovaries to the uterus. Now, results of a ...

NEW YORK (Reuters Health) - New research suggests that fallopian tube cells rather than ovarian surface cells are the probable site of origin of most cases of ovarian serous carcinoma, the most common ...